Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lamarche, J.B.
Côté, M.
and
Lemieux, B.
1980.
The Cardiomyopathy of Friedreich's Ataxia Morphological Observations in 3 Cases.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 7,
Issue. 4,
p.
389.
Barbeau, A.
Bouchard, R.
Cloutier, T.
and
Bouchard, J.P.
1982.
Reduced Formation of Hippuric Acid After Oral Benzoic Acid in Friedreich’s Ataxia.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 9,
Issue. 2,
p.
217.
Barbeau, André
1982.
Friedreich’s Disease 1982: Etiologic Hypotheses A personal analysis.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 9,
Issue. 2,
p.
243.
Babcock, Michael
de Silva, Deepika
Oaks, Robert
Davis-Kaplan, Sandra
Jiralerspong, Sarn
Montermini, Laura
Pandolfo, Massimo
and
Kaplan, Jerry
1997.
Regulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of Frataxin.
Science,
Vol. 276,
Issue. 5319,
p.
1709.
Richardson, Des R
1999.
The therapeutic potential of iron chelators.
Expert Opinion on Investigational Drugs,
Vol. 8,
Issue. 12,
p.
2141.
O'Brian, Mark R.
1999.
Iron Metabolism.
p.
1.
Becker, Erika
and
Richardson, Des R.
2001.
Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia.
The International Journal of Biochemistry & Cell Biology,
Vol. 33,
Issue. 1,
p.
1.
Richardson, D.R.
Mouralian, C.
Ponka, P.
and
Becker, E.
2001.
Development of potential iron chelators for the treatment of Friedreich’s ataxia: ligands that mobilize mitochondrial iron.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease,
Vol. 1536,
Issue. 2-3,
p.
133.
Becker, Erika M.
Greer, Judith M.
Ponka, Prem
and
Richardson, Des R.
2002.
Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in Friend cells: characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization.
Blood,
Vol. 99,
Issue. 10,
p.
3813.
Pandolfo, Massimo
2002.
Response to Commentary 1: Abnormal Mitochondrial Iron Metabolism in Friedreich Ataxia.
Blood Cells, Molecules, and Diseases,
Vol. 29,
Issue. 3,
p.
550.
Nichol, Helen
Gakh, Oleksandr
O'Neill, Heather A.
Pickering, Ingrid J.
Isaya, Grazia
and
George, Graham N.
2003.
Structure of Frataxin Iron Cores: An X-ray Absorption Spectroscopic Study.
Biochemistry,
Vol. 42,
Issue. 20,
p.
5971.
Richardson, DR
2003.
Friedreich’s ataxia: iron chelators that target the mitochondrion as a therapeutic strategy?.
Expert Opinion on Investigational Drugs,
Vol. 12,
Issue. 2,
p.
235.
Buyse, G.
Mertens, L.
Di Salvo, G.
Matthijs, I.
Weidemann, F.
Eyskens, B.
Goossens, W.
Goemans, N.
Sutherland, G. R.
and
Van Hove, J. L.K.
2003.
Idebenone treatment in Friedreich’s ataxia.
Neurology,
Vol. 60,
Issue. 10,
p.
1679.
Terskikh, Alexey V.
Miyamoto, Toshihiro
Chang, Cynthia
Diatchenko, Luda
and
Weissman, Irving L.
2003.
Gene expression analysis of purified hematopoietic stem cells and committed progenitors.
Blood,
Vol. 102,
Issue. 1,
p.
94.
Lange, Heike
Mühlenhoff, Ulrich
Denzel, Martin
Kispal, Gyula
and
Lill, Roland
2004.
The Heme Synthesis Defect of Mutants Impaired in Mitochondrial Iron-Sulfur Protein Biogenesis Is Caused by Reversible Inhibition of Ferrochelatase.
Journal of Biological Chemistry,
Vol. 279,
Issue. 28,
p.
29101.
Miranda, Carlos J
Santos, Manuela M
Ohshima, Keiichi
Tessaro, Marco
Sequeiros, Jorge
and
Pandolfo, Massimo
2004.
Frataxin overexpressing mice.
FEBS Letters,
Vol. 572,
Issue. 1-3,
p.
281.
Schoenfeld, Robert A.
Napoli, Eleonora
Wong, Alice
Zhan, Shan
Reutenauer, Laurence
Morin, Dexter
Buckpitt, Alan R.
Taroni, Franco
Lonnerdal, Bo
Ristow, Michael
Puccio, Hélène
and
Cortopassi, Gino A.
2005.
Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells.
Human Molecular Genetics,
Vol. 14,
Issue. 24,
p.
3787.
Wilson, Robert B.
2006.
Iron Dysregulation in Friedreich Ataxia.
Seminars in Pediatric Neurology,
Vol. 13,
Issue. 3,
p.
166.
Zanella, Isabella
Derosas, Manuela
Corrado, Marcella
Cocco, Emiliano
Cavadini, Patrizia
Biasiotto, Giorgio
Poli, Maura
Verardi, Rosanna
and
Arosio, Paolo
2008.
The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease,
Vol. 1782,
Issue. 2,
p.
90.
Santos, Renata
Lefevre, Sophie
Sliwa, Dominika
Seguin, Alexandra
Camadro, Jean-Michel
and
Lesuisse, Emmanuel
2010.
Friedreich Ataxia: Molecular Mechanisms, Redox Considerations, and Therapeutic Opportunities.
Antioxidants & Redox Signaling,
Vol. 13,
Issue. 5,
p.
651.